secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERU INC. (VERU)
CIK:        0000863894
Form:       8-K
Filed at:   2026-05-13T11:00:07+00:00
Accession:  0001193125-26-220569
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veru Q2 net loss $2.7M; PLATEAU trial interim analysis expected Q1 2027
-----------------------------------------------------------------------

- Net loss $2.7M ($0.12/sh) vs $7.9M ($0.54) in Q2 2025; operating loss $7.2M.
- Cash, equivalents & restricted cash $27.6M as of Mar 31, 2026, up from $15.8M Sep 30, 2025.
- Phase 2b PLATEAU trial actively enrolling; interim analysis on lean/fat mass expected Q1 2027.
- R&D expenses $3.1M (down from $3.9M); G&A $4.1M (down from $5.2M) vs year-ago quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/863894/000119312526220569/0001193125-26-220569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/863894/000119312526220569/d114190d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-220569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer